Galway Bay fm newsroom - A clinical trial led by an NUI Galway professor has shown promising results for patients with a rare blood cancer.
Multiple Myeloma is a blood cancer which forms in a type of white blood cell called a plasma cell.
Blood Cancer Network Ireland, which is led by Professor Michael O'Dwyer, has now completed the first phase of a new trial which has shown promising results.
Approximately 250 people in Ireland are diagnosed with the rare cancer every year and 170 die as a result.
Irish patients with the condition are the first patients worldwide to take part in the new drug trial to develop a more effective treatment.
Advertisement
